FENTON MARY KAY (Chief Financial Officer) received a stock award from CULLINAN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/2/2026ACC: 0001193125-26-294863
Officer· Chief Financial Officer
Since Feb 2026
+1.54K
Net shares
Net buyer
$13.3K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1.54K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.54K
Price / share
$8.60
Trade value
$13.25K
% of position
1.2%
6/30/2026
126.38K→127.92K
Total
Net shares
+1.54K
Net value
$13.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2026 | A · Award | +1.54K | $8.60 | $13.25K | 1.2% | 126.38K | 127.92K |
| Total | +1.54K | $13.25K | ||||||
Derivative Transactions0
No derivative transactions reported